Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
My Cancer Genome
Vanderbilt University’s My Cancer Genome app provides a great deal of information related to the genetics of cancer and genetically informed cancer therapeutics. The app is divided into two sections. On the “variants” page users can browse (or search) diseases, genes, and gene variants. For example, selecting a specific disease displays a description of that type of cancer as well as a list of associated genes and variants. The other section of the app deals with drugs, allowing users to browse by drug name, drug class, or target. Unfortunately, selecting on a specific drug class (such as topoisomerase inhibitors) only directs users to a list of other drugs of that class, rather than providing additional details about the mechanism of action of that class of drug.